2012 Aarkstore.com || Cangene Corporation – Product Pipeline Review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Cangene Corporation – Product Pipeline Review – 2012
http://www.aarkstore.com/reports/Cangene-Corporation-Product-Pipeline-
Review-2012-217935.html
RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml
Summary
Global Market Direct’s pharmaceuticals report, “Cangene Corporation - Product
Pipeline Review - 2012” provides data on the Cangene Corporation’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Cangene Corporation’s corporate website, SEC filings,
investor presentations and featured press releases, both from Cangene Corporation
and industry-specific third party sources, put together by Global Markets Direct’s
team.
Scope
- Cangene Corporation - Brief Cangene Corporation overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Cangene Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,

2. including the combination treatment modalities, across the globe.
Table of contents:
List of Tables 4
List of Figures 4
Cangene Corporation Snapshot 5
Cangene Corporation Overview 5
Key Information 5
Key Facts 5
Cangene Corporation – Research and Development Overview 6
Key Therapeutic Areas 6
Cangene Corporation – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Cangene Corporation – Pipeline Products Glance 10
Cangene Corporation – Late Stage Pipeline 10
Phase III Products/Combination Treatment Modalities 10
Cangene Corporation – Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Cangene Corporation – Drug Profiles 12
Anthrax Immune Globulin 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Botulism Antitoxin Heptavalent 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Ebola/Marburg Immune Globulins 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Immune Globulin Intravenous Program 16
Product Description 16
Mechanism of Action 16
R&D Progress 16

3. List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review&PubId=&pagenum=1
Avir Green Hills Biotechnology AG – Product Pipeline Review – 2012
BIOALVO S.A. – Product Pipeline Review – 2012
Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Cardio3 BioSciences SA – Product Pipeline Review – 2012
Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Enzon Pharmaceuticals, Inc. – Product Pipeline Review – 2012
iCo Therapeutics Inc. – Product Pipeline Review – 2012
Neurocrine Biosciences, Inc. – Product Pipeline Review – 2012
Mersana Therapeutics, Inc. – Product Pipeline Review – 2012
Nexgenix Pharmaceuticals, LLC – Product Pipeline Review – 2012

4. Nuon Therapeutics, Inc. – Product Pipeline Review – 2012
Osmotica Pharmaceutical Corp. – Product Pipeline Review – 2012
SymBio Pharmaceuticals Limited – Product Pipeline Review – 2012
ProStrakan Group plc – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
You can also request for sample page of above mention reports on
sample@aarkstore.com
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com